Page last updated: 2024-12-07

lysyl-lysyl-glycyl-glutamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lysyl-lysyl-glycyl-glutamic acid: beta endorphin C-terminal tetrapeptide; RN given for all-(L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126368
SCHEMBL ID1370325
MeSH IDM0143202

Synonyms (9)

Synonym
beta-endorphin mpf
(2s)-2-[[2-[[(2s)-6-amino-2-[[(2s)-2,6-diaminohexanoyl]amino]hexanoyl]amino]acetyl]amino]pentanedioic acid
l-glutamic acid, n-(n-(n2-l-lysly-l-lysyl)glycyl)-
lysyl-lysyl-glycyl-glutamic acid
SCHEMBL1370325
melanotropin-potentiating factor
(s)-2-(2-((s)-6-amino-2-((s)-2,6-diaminohexanamido)hexanamido)acetamido)pentanedioic acid
n-[2-({6-amino-2-[(2,6-diamino-1-hydroxyhexylidene)amino]-1-hydroxyhexylidene}amino)-1-hydroxyethylidene]glutamic acid
DTXSID90992905

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationships are biphasic ("bell shaped"), maximal responses being obtained with 10(-6) M concentrations of MPF."( Trophic effects of melanotropin-potentiating factor (MPF) on cultures of cells of the central nervous system.
Allen, YS; Ensor, DM; Miles, JB; Morley, JS; Owen, DB, 1997
)
0.3
" the dose-response curve is bell-shaped."( The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses.
Ensor, DM; Miles, JB; Morley, JS; Owen, DL, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (75.00)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]